Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C
Amanda Mocroft(University of Copenhagen), Vincent Soriano(Fundación Instituto Valenciano de Oncología), Ole Kirk(University of Copenhagen), Jacek Gąsiorowski(Copenhagen University Hospital), Jean‐Paul Viard, Jürgen K. Rockstroh(University of Bonn), Antonio Chiesi(Istituto Superiore di Sanità), Saulius Chplinskas(Lithuanian Social Research Centre)
Cited by 14
Related Papers
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
One Biocatalyst–Many Applications: The Use of Candida Antarctica B-Lipase in Organic Synthesis
|Biocatalysis and Biotransformation|1998|682